Jim Greenwood, BIO
October 8, 2019 12:02 PM EDT
People

Jim Green­wood set to de­part from BIO af­ter US elec­tions — vows to en­sure law­mak­ers don't 'kill in­no­va­tion'

Natalie Grover

Reporter

The her­culean US drug lob­by is los­ing one of its flag­bear­ers: BIO CEO Jim Green­wood.

For more than 14 years Green­wood has led BIO, which …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

Eli Lil­ly stock­piles $548M of oral weight loss drug ahead of launch

Will CRISPR mat­ter?

FDA says Ozem­pic, We­govy short­age is over

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times